Search for other papers by Kathrin Zopf in
Google Scholar
PubMed
Search for other papers by Kathrin R Frey in
Google Scholar
PubMed
Search for other papers by Tina Kienitz in
Google Scholar
PubMed
Search for other papers by Manfred Ventz in
Google Scholar
PubMed
Search for other papers by Britta Bauer in
Google Scholar
PubMed
Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
records. Patients under the age of 18 years, patients diagnosed with bone metastasis, secondary adrenal insufficiency, adrenal insufficiency due to long-term pharmacological glucocorticoid treatment, adrenocortical carcinoma and patients with less than 12
Search for other papers by Ramjan Sanas Mohamed in
Google Scholar
PubMed
Search for other papers by Biyaser Abuelgasim in
Google Scholar
PubMed
Search for other papers by Sally Barker in
Google Scholar
PubMed
Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Niamh M Martin in
Google Scholar
PubMed
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Search for other papers by Emma L Williams in
Google Scholar
PubMed
Search for other papers by Sarah Darch in
Google Scholar
PubMed
Search for other papers by Whitlock Matthew in
Google Scholar
PubMed
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Tricia Tan in
Google Scholar
PubMed
Search for other papers by Florian Wernig in
Google Scholar
PubMed
positive histology. The diagnosis of adrenal CS was established by suppressed adrenocorticotrophic hormone (ACTH) levels in the context of hypercortisolaemia and histology in keeping with a cortisol-producing adenoma/adrenocortical carcinoma. Patients
Search for other papers by Rachel Forfar in
Google Scholar
PubMed
Search for other papers by Mashal Hussain in
Google Scholar
PubMed
Search for other papers by Puneet Khurana in
Google Scholar
PubMed
Search for other papers by Jennifer Cook in
Google Scholar
PubMed
Search for other papers by Steve Lewis in
Google Scholar
PubMed
Search for other papers by Dillon Popat in
Google Scholar
PubMed
Search for other papers by David Jackson in
Google Scholar
PubMed
Search for other papers by Ed McIver in
Google Scholar
PubMed
Search for other papers by Jeff Jerman in
Google Scholar
PubMed
Search for other papers by Debra Taylor in
Google Scholar
PubMed
Search for other papers by Adrian JL Clark in
Google Scholar
PubMed
Search for other papers by Li F Chan in
Google Scholar
PubMed
801 – 812 . ( https://doi.org/10.1210/clinem/dgab749 ) 16 Parmar J Key RE Rainey WE . Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line . Journal of Clinical Endocrinology and Metabolism 2008 93 4542
Search for other papers by Zherui Fu in
Google Scholar
PubMed
Search for other papers by Yi Lai in
Google Scholar
PubMed
Search for other papers by Qianfei Wang in
Google Scholar
PubMed
Search for other papers by Feng Lin in
Google Scholar
PubMed
Search for other papers by Jiaping Fang in
Google Scholar
PubMed
figure). ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid
Search for other papers by Natalie Rogowski-Lehmann in
Google Scholar
PubMed
Search for other papers by Aikaterini Geroula in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Felix Megerle in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Anthony Stell in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
metastasized PGL 12 Metastatic disease Urinary retention let to the diagnosis of an adrenal tumor (with the initial suspicion of adrenocortical carcinoma) with the final diagnosis of metastatic PGL 13 Metastatic disease Abdominal CT scan was
Search for other papers by Cristina Lamas in
Google Scholar
PubMed
Search for other papers by Elena Navarro in
Google Scholar
PubMed
Search for other papers by Anna Casterás in
Google Scholar
PubMed
Search for other papers by Paloma Portillo in
Google Scholar
PubMed
Search for other papers by Victoria Alcázar in
Google Scholar
PubMed
Search for other papers by María Calatayud in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez-Escolá in
Google Scholar
PubMed
Search for other papers by Julia Sastre in
Google Scholar
PubMed
Search for other papers by Evangelina Boix in
Google Scholar
PubMed
Search for other papers by Lluis Forga in
Google Scholar
PubMed
Search for other papers by Almudena Vicente in
Google Scholar
PubMed
Search for other papers by Josep Oriola in
Google Scholar
PubMed
Search for other papers by Jordi Mesa in
Google Scholar
PubMed
Search for other papers by Nuria Valdés in
Google Scholar
PubMed
). Cause of death Number of patients Months after diagnosis Surgical complication 1 10 Gastroenteropancreatic tumor 3 40–177–208 Adrenocortical carcinoma 1 205 Metastatic adenocarcinoma 1 62 Acute
Search for other papers by Ahmet Uçar in
Google Scholar
PubMed
Search for other papers by Nurçin Saka in
Google Scholar
PubMed
Search for other papers by Firdevs Baş in
Google Scholar
PubMed
Search for other papers by Nihal Hatipoğlu in
Google Scholar
PubMed
Search for other papers by Rüveyde Bundak in
Google Scholar
PubMed
Search for other papers by Feyza Darendeliler in
Google Scholar
PubMed
( n =1), or adrenocortical carcinoma ( n =1). Forty-five BMI- and WC-matched peers born AGA were recruited consecutively from prepubertal girls followed in our Well Child Care Clinic. Data related to family history of CAD were retrieved from medical
Search for other papers by Katherine Van Loon in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Jennifer Keiser in
Google Scholar
PubMed
Search for other papers by Cendy Carrasco in
Google Scholar
PubMed
Search for other papers by Katherine Glass in
Google Scholar
PubMed
Search for other papers by Maria-Teresa Ramirez in
Google Scholar
PubMed
Search for other papers by Sarah Bobiak in
Google Scholar
PubMed
Search for other papers by Eric K Nakakura in
Google Scholar
PubMed
Search for other papers by Alan P Venook in
Google Scholar
PubMed
Search for other papers by Manisha H Shah in
Google Scholar
PubMed
Search for other papers by Emily K Bergsland in
Google Scholar
PubMed
having a carcinoid tumor, pancreatic NET, high-grade neuroendocrine carcinomas (NECs), sympathetic paraganglioma or pheochromocytoma, or other NETs (adenocarcinoid tumors or adrenocortical carcinomas). The primary site of the tumor, functionality of the
Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China
Search for other papers by Tao Mei in
Google Scholar
PubMed
Search for other papers by Jianhe Zhang in
Google Scholar
PubMed
Search for other papers by Liangfeng Wei in
Google Scholar
PubMed
Search for other papers by Xingfeng Qi in
Google Scholar
PubMed
Search for other papers by Yiming Ma in
Google Scholar
PubMed
Search for other papers by Xianhua Liu in
Google Scholar
PubMed
Search for other papers by Shaohua Chen in
Google Scholar
PubMed
Search for other papers by Songyuan Li in
Google Scholar
PubMed
Search for other papers by Jianwu Wu in
Google Scholar
PubMed
Search for other papers by Shousen Wang in
Google Scholar
PubMed
Fenske W Völker HU Adam P Hahner S Johanssen S Wortmann S Schmidt M Morcos M Müller-Hermelink HK Allolio B , et al . Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma . Endocrine
University Rehabilitation Institute Republic of Slovenia, Ljubljana, Slovenia
Search for other papers by Ana Podbregar in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Tomaž Kocjan in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Matej Rakuša in
Google Scholar
PubMed
Clinical Institute of Radiology, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Peter Popović in
Google Scholar
PubMed
Clinical Institute of Radiology, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Manca Garbajs in
Google Scholar
PubMed
Search for other papers by Katja Goricar in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Andrej Janez in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Center Ljubljana, Ljubljana, Slovenia
Search for other papers by Mojca Jensterle in
Google Scholar
PubMed
in size and that do not progress to adrenocortical carcinoma, 2016 ESE-ENSAT European guidelines for AIs discourage repeated imaging re-assessment ( 1 ) because of the substantial health economic burden and increased radiation exposure from